Key transcriptional regulators, such as c-Myc, p53, and HIF-1, further reinforce this metabolic bias by upregulating genes that encode glucose transporters and glycolytic enzymes, thereby intensifying the glycolytic phenotype characteristic of CRC cells (182). Here, MYC is linked to colorectal carcinoma.